文献速递脊柱脊髓外科神经肿瘤

激素难治性转移性前列腺癌所致高级别脊髓压迫的手术减压

Surgical Decompression of High-Grade Spinal Cord Compression from Hormone Refractory Metastatic Prostate Cancer.
PubMed 文献 · Neurosurgery · 2018-01-01

该回顾性研究纳入1993年6月至2014年8月在本机构接受手术的139例前列腺癌脊柱转移患者共157个手术病灶,其中126例143个病灶因高级别硬膜外脊髓压迫行减压。87%患者为激素难治性前列腺癌,61%曾放疗失败。激素难治性患者中位总生存6.6个月(95%CI:5.6-8.6),激素敏感患者为16.3个月(95%CI:4.0-26.6)。

要点

  • 接受脊柱手术的前列腺癌转移患者多数为激素难治性,激素敏感者少见出现症状性脊髓压迫或脊柱不稳。
  • 激素难治性患者中位总生存6.6个月(95%CI:5.6-8.6),显著短于激素敏感者的16.3个月(95%CI:4.0-26.6)。
  • 推荐对激素难治性患者警惕监测硬膜外脊髓压迫及脊柱不稳的症状与体征。

核心结论

  • 接受前列腺癌脊柱转移手术的患者多数对激素治疗难治,提示激素敏感性前列腺癌患者不易发生症状性脊髓压迫或脊柱不稳。
  • 相当数量激素难治性前列腺癌患者因脊髓压迫出现神经功能缺损。
  • 推荐对激素难治性患者警惕监测硬膜外脊髓压迫及脊柱不稳的症状与体征。
  • 与激素敏感患者相比,激素难治性患者术后生存期明显更短,可能影响手术决策。

研究设计与样本

  • 回顾性病历审查,纳入1993年6月至2014年8月在本机构接受手术治疗前列腺癌脊柱转移的所有患者。
  • 共139例患者、157个手术病灶;其中126例患者、143个病灶因高级别硬膜外脊髓压迫行减压。

主要发现

  • 术前69%患者存在运动功能缺损,21%无法行走,其中32%因运动无力所致。
  • 手术时87%患者为激素难治性前列腺癌,61%既往放疗失败。
  • 激素难治性患者中位总生存6.6个月(95%CI:5.6-8.6),激素敏感患者中位总生存16.3个月(95%CI:4.0-26.6)。

临床怎么用

  • 作者推荐对激素难治性前列腺癌患者警惕监测硬膜外脊髓压迫及脊柱不稳的症状与体征。
  • 作者认为激素难治性患者术后生存期明显短于激素敏感患者,可能影响手术决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spine and nonspine skeletal metastases occur in more than 80% of patients with prostate cancer. OBJECTIVE: To examine the characteristics of the patient population undergoing surgery for the treatment of prostate cancer metastatic to the spine. METHODS: A retrospective chart review was performed on all patients treated at our institution from June 1993 to August 2014 for surgical management of metastatic spine disease from prostate cancer. RESULTS: During the study period, 139 patients with 157 surgical lesions underwent surgery for metastatic spine disease. Decompression for high-grade epidural spinal cord compression was required for 126 patients with 143 lesions. Preoperatively, 69% had a motor deficit and 21% were nonambulatory, with 32% due to motor weakness. At surgery, 87% of patients had hormone-refractory prostate cancer (HRPC) and 61% failed prior radiation. Median overall survival for HRPC patients was 6.6 mo (95% confidence interval [CI]: 5.6-8.6) while the median overall survival for hormone-sensitive patients was 16.3 mo (95% CI: 4.0-26.6). CONCLUSION: The majority of patients undergoing surgery for prostate cancer metastases to the spine were refractory to hormone therapy, indicating that patients with hormone-sensitive prostate cancer are unlikely to develop symptomatic spinal cord compression or spinal instability. A significant number of HRPC patients presented with neurological deficits attributable to spinal cord compression. Vigilant monitoring for the development of signs and symptoms of epidural spinal cord compression and spinal instability in hormone-refractory patients is recommended. Surgical decision making may be affected by the much shorter postoperative survival for HRPC patients as compared to patients with hormone-sensitive cancer.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Chohan MO, Kahn S, Cederquist G, et al. Surgical Decompression of High-Grade Spinal Cord Compression from Hormone Refractory Metastatic Prostate Cancer. Neurosurgery. 2018. PMID: 28541420. doi:10.1093/neuros/nyx292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。